Videos de Experimentos Relacionados
Terapéutica de la gota: nuevos medicamentos para una vieja enfermedad
Christopher M Burns1, Robert L Wortmann
1Dartmouth Medical School, Lebanon, NH 03756, USA. chris.burns@hitchcock.org
Lancet (London, England)
|August 20, 2010
Resumen
Los nuevos tratamientos para la gota, como el febuxostat, ofrecen mejores opciones. Esta revisión cubre los ensayos clínicos de febuxostat, las terapias de uricasa y otros medicamentos emergentes para la gota, enfatizando los enfoques de tratamiento racional.
Área de la Ciencia:
- Manejo de la gota y la hiperuricemia.
- Intervenciones farmacológicas para condiciones inflamatorias.
- Mecanismos de transporte renal de los mecanismos de transporte renal.
Sus antecedentes:
- El tratamiento de la gota está evolucionando con las nuevas aprobaciones de medicamentos y la investigación en curso.
- Comprender el transporte de ácido úrico y las vías inflamatorias es clave para desarrollar nuevas terapias.
- El febuxostat, un inhibidor de la xantina oxidasa, representa un avance significativo.
Objetivo del estudio:
- Para revisar los ensayos clínicos de febuxostat para el tratamiento de la gota.
- Discutir terapias emergentes, incluidas las uricasas modificadas y las nuevas moléculas pequeñas.
- Proporcionar orientación sobre el uso racional de los medicamentos existentes y nuevos para la gota.
Principales métodos:
- Revisión enfocada de los datos de ensayos clínicos para el febuxostat.
- Resumen de los hallazgos de los estudios sobre pegloticasa (uricasa pegilada).
- Datos recopilados sobre medicamentos en desarrollo como RDEA594 y inhibidores de IL-1.
Principales resultados:
- La aprobación de Febuxostat marca una nueva era en el manejo de la gota.
- La pegloticasa es prometedora para los casos graves de gota.
- Se están desarrollando varios fármacos novedosos dirigidos a diferentes vías.
Conclusiones:
- Los avances en el tratamiento de la gota requieren un enfoque racional y basado en la evidencia.
- Es esencial una cuidadosa consideración de los beneficios y riesgos de los nuevos medicamentos.
- El panorama de la farmacoterapia de la gota se está expandiendo rápidamente.
Videos de Conceptos Relacionados
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications